SA result of applying the sensitivity of 90% to the pre-screening questionnaire
When applying the sensitivity of 90% to the pre-screening questionnaire, and assuming the same prevalence (0,07% for B1 and 0,02% for B2) between responders and non-responders, the cost per case detected was substantially lower for both B1 (a reduction from 22.556 EURO to 11.360 EURO) and B2 (a reduction from 27.023 to 17.334 EURO).